ESTHER CHIN: Open Payments
NPI 1154074052 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,506 in 64 payments from 15 companies in 2025. Trend: 2023 $356 · 2024 $815 · 2025 $1,506
Food & beverage: $1,506
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $281 |
| GlaxoSmithKline, LLC. | 11 | $222 |
| CSL Behring | 11 | $215 |
| ARS Pharmaceuticals Operations, Inc. | 11 | $184 |
| Novartis Pharmaceuticals Corporation | 5 | $105 |
| Regeneron Healthcare Solutions, Inc. | 3 | $99 |
| BioCryst US Sales Co., LLC | 2 | $62 |
| Grifols USA, LLC | 3 | $58 |
| PFIZER INC. | 2 | $52 |
| Azurity Pharmaceuticals, Inc. | 2 | $47 |
Products named: TEZSPIRE, NEFFY, NUCALA, DUPIXENT, Andembry, Haegarda, Rhapsido, ORLADEYO.
Industry payments across GA — which companies pay providers there.
